What is LeafWorks?
LeafWorks is a specialized botanical genomics firm providing comprehensive genetic testing solutions, including DNA Sex Tests and Pathogen ID tests. The company also offers certifications for feminized seeds and supply chains, aiming to bolster transparency and enhance plant quality for its clientele in the natural products industry. Their expertise extends to functional mushrooms, offering consulting and testing services that ensure authenticity and reliability in natural product offerings. LeafWorks is committed to supporting modern breeding techniques and providing clients with the confidence to verify and certify their plant materials.
How much funding has LeafWorks raised?
LeafWorks has raised a total of $1.9M across 3 funding rounds:
Series A
$1M
Private Equity
$700K
Private Equity
$200K
Series A (2020): $1M with participation from Bonaventure Equity LLC
Private Equity (2026): $700K, investors not publicly disclosed
Private Equity (2026): $200K, investors not publicly disclosed
Key Investors in LeafWorks
Bonaventure Equity LLC
Bonaventure Equity LLC is an investor in LeafWorks' Series A round. Further details on their investment focus are not specified.
What's next for LeafWorks?
The substantial enterprise-level funding and recent strategic investment position LeafWorks for significant expansion and innovation. This capital infusion will likely fuel advancements in their genetic testing technologies and broaden their market reach within the burgeoning cannabis, hemp, and functional mushroom sectors. LeafWorks is poised to further solidify its leadership in botanical genomics, driving greater transparency and reliability across the natural products supply chain through enhanced genetic verification and certification services.
See full LeafWorks company page
